Secukinumab in the Treatment of Moderate-to-Severe Hidradenitis Suppurativa: Results of an Open-Label Trial.

Click here to read the full article @ Journal of the American Academy of Dermatology
Subscribe to receive the latest articles tailored to your interests

Suggested articles